CD62L (L-Selectin) secondary antibody product blog
Tags: Secondary Antibody; CD62L (L-Selectin); CD62L (L-Selectin) secondary antibody;
The CD62L (L-Selectin) n/a (Catalog #MBS673418) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The Rat Anti-Mouse CD62L/L-selectin-PE reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s CD62L (L-Selectin) can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry; Immunohistochemistry (Frozen Sections); Immunoprecipitation.Research Application(s): In vivo and in vitro blocking of adhesion
Cytotoxicity studies
Flow Cytometry Suggested Dilution: <= 0.1 ug/10^6 cells. Researchers should empirically determine the suitability of the CD62L (L-Selectin) n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Rat Anti-Mouse CD62L/L-selectin-PE with the following immunoassay(s):
Testing Data
Immunogen: C3H/eb cloned mouse B lymphoma 38C-13. Characterization: To ensure lot-to-lot consistency, each batch of monoclonal antibody is tested by flow cytometry to conform to characteristics of a standard reference reagent. Representative data are included in this product insert. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD62L (L-Selectin) are readily searchable from our website. Different antibodies against the same target such as CD62L (L-Selectin) may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.